Research Articles | Page 4 | Aplastic Anemia and MDS International Foundation (AAMDSIF) Return to top.

Research Articles

  1. Home
  2. Research

Compiled for your convenience are articles on bone marrow failure research and treatment from the world’s major journals on hematology / oncology.

Article Title Original Publication Date Journal Bone Marrow Disease
Patient preferences and quality of life implications of ravulizumab (every 8 weeks) and eculizumab (every 2 weeks) for the treatment of paroxysmal nocturnal hemoglobinuria. Sep 2020 PloS One Paroxysmal Nocturnal Hemoglobinuria (PNH)
Treatment of newly diagnosed severe aplastic anemia in children: Evidence-based recommendations May 2024 Pediatric Blood & Cancer Aplastic Anemia
Eltrombopag in children with severe aplastic anemia Apr 2021 Pediatric Blood & Cancer Aplastic Anemia, Pediatric
A study assessing the feasibility of randomization of pediatric and young adult patients between matched unrelated donor bone marrow transplantation and immune-suppressive therapy for newly diagnosed severe aplastic anemia: A joint pilot trial of the Nort Aug 2020 Pediatric Blood & Cancer Aplastic Anemia, Pediatric
Diagnosis and treatment of pediatric myelodysplastic syndromes: A survey of the North American Pediatric Aplastic Anemia Consortium Aug 2020 Pediatric Blood & Cancer Aplastic Anemia, Myelodysplastic Syndromes (MDS), Pediatric
Experience of life quality from patients with aplastic anemia: a descriptive qualitative study Dec 2023 Orphanet Journal of Rare Diseases Aplastic Anemia
Patterns of Diagnostic Evaluation and Determinants of Treatment in Older Patients With Non-transfusion Dependent Myelodysplastic Syndromes Oct 2023 Oncologist Myelodysplastic Syndromes (MDS)
Implications of TP53 allelic state for genome stability, clinical presentation and outcomes in myelodysplastic syndromes Aug 2020 Nature Medicine Myelodysplastic Syndromes (MDS)
Myelodysplastic Syndromes Treatment (PDQ®): Patient Version Mar 2019 National Cancer Institute Myelodysplastic Syndromes (MDS)
TERC haploid cell reprogramming: a novel therapeutic strategy for aplastic anemia Jun 2023 Molecular Medicine Aplastic Anemia